TaqMan PCR assay in the control of RNA normalization in human post-mortem brain tissue

被引:63
作者
Barrachina, Marta
Castano, Esther
Ferrer, Isidro
机构
[1] Hosp Univ bellvitge, IDIBELL, Serv Anat Patol, Inst Neuropathol, Lhospitalet De Llobregat 08907, Spain
[2] Univ Barcelona, Serv Cient Tecn, Unitat Bellvitge, E-08007 Barcelona, Spain
关键词
TaqMan; post-mortem brain; RNA;
D O I
10.1016/j.neuint.2006.01.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The brain tissue obtained after death is subjected to several circumstances that can affect RNA integrity. The present study has been directed to reveal possible pitfalls and to control RNA normalization in post-mortem samples in order to recognize the limitations and minimize errors when using TaqMan PCR technology. This has been carried out in samples of the frontal cortex in a series of control and diseased cases covering Parkinson's disease, dementia with Lewy bodies pure form and common form, and Alzheimer's disease. Special attention has been paid to the value of the agonal state, post-mortem delay and pH of the nervous tissue as approximate predictors of the quality of RNA, as well as to the use of the Bioanalyzer to confirm RNA preservation. In addition, since possible disease-modified mRNAs have to be normalized with ideal unaltered RNAs, TaqMan (R) human endogenous control plates have been used to determine the endogenous control most appropriate for the study. beta-glucuronidase (GUS) and beta-actin were good endogenous controls because their expression levels showed a small variation across a representative number of control and pathological cases. RNA stability was also analysed in a paradigm mimicking cumulative delay in tissue processing. GUS mRNA levels were not modified although beta-actin mRNA levels showed degradation at 22 h. Finally, the control of RNA degradation for the normalization of genes of interest was also tested. mRNA expression levels for superoxide dismutase 1 (SOD1) and metalloproteinase domain 22 (ADAM22) were examined at several artificial post-mortem times, and their expression levels compared with those for putative controls beta-actin and GUS. In our paradigm, the expressions of SOD 1 and ADAM22 were apparently not modified when normalized with beta-actin. Yet their expression levels were reduced with post-mortem delay when values were normalized with GUS. Taken together, these observations point to practical consequences in TaqMan PCR studies. Short post-mortem delays and acceptable pH of the brain are not sufficient to rule out RNA degradation. The selection of adequate endogenous controls is pivotal in the study. beta-actin and GUS are found to be good endogenous controls in these pathologies, although GUS but not beta-actin expression levels are preserved in samples with long post-mortem delay. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:276 / 284
页数:9
相关论文
共 22 条
  • [1] [Anonymous], 2003, NEURODEGENERATION MO
  • [2] BRAAK H, 1999, NEURODEGENERATIVE AG, P475
  • [3] DNA chip technology in brain banks: Confronting a degrading world
    Buesa, C
    Maes, T
    Subirada, F
    Barrachina, M
    Ferrer, I
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2004, 63 (10) : 1003 - 1014
  • [4] Recovery and expression of messenger RNA from postmortem human brain tissue
    Cummings, TJ
    Strum, JC
    Yoon, LW
    Szymanski, MH
    Hulette, CM
    [J]. MODERN PATHOLOGY, 2001, 14 (11) : 1157 - 1161
  • [5] The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: Selective mRNA vulnerability and comparison with their encoded proteins
    Harrison, PJ
    Heath, PR
    Eastwood, SL
    Burnet, PWJ
    McDonald, B
    Pearson, RCA
    [J]. NEUROSCIENCE LETTERS, 1995, 200 (03) : 151 - 154
  • [6] Application of real-time quantitative polymerase chain reaction to quantification of glutamate receptor gene expression in the vestibular brainstem and cerebellum
    Horii, A
    Smith, PF
    Darlington, CL
    [J]. BRAIN RESEARCH PROTOCOLS, 2002, 9 (01): : 77 - 83
  • [7] BIOLOGICAL STABILITY OF MESSENGER-RNA ISOLATED FROM HUMAN POSTMORTEM BRAIN COLLECTIONS
    LEONARD, S
    LOGEL, J
    LUTHMAN, D
    CASANOVA, MF
    KIRCH, D
    FREEDMAN, R
    [J]. BIOLOGICAL PSYCHIATRY, 1993, 33 (06) : 456 - 466
  • [8] Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions
    Li, JZ
    Vawter, MP
    Walsh, DM
    Tomita, H
    Evans, SJ
    Choudary, PV
    Lopez, JF
    Avelar, A
    Shokoohi, V
    Chung, T
    Mesarwi, O
    Jones, EG
    Watson, SJ
    Akil, H
    Bunney, WE
    Myers, RM
    [J]. HUMAN MOLECULAR GENETICS, 2004, 13 (06) : 609 - 616
  • [9] Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies
    McKeith, IG
    Ballard, CG
    Perry, RH
    Ince, PG
    O'Brien, JT
    Neill, D
    Lowery, K
    Jaros, E
    Barber, R
    Thompson, P
    Swann, A
    Fairbairn, AF
    Perry, EK
    [J]. NEUROLOGY, 2000, 54 (05) : 1050 - 1058
  • [10] Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
    McKeith, IG
    Galasko, D
    Kosaka, K
    Perry, EK
    Dickson, DW
    Hansen, LA
    Salmon, DP
    Lowe, J
    MIrra, SS
    Byrne, EJ
    Lennox, G
    Quinn, NP
    Edwardson, JA
    Ince, PG
    Bergeron, C
    Burns, A
    Miller, BL
    Lovestone, S
    Collerton, D
    Jansen, ENH
    Ballard, C
    deVos, RAI
    Wilcock, GK
    Jellinger, KA
    Perry, RH
    [J]. NEUROLOGY, 1996, 47 (05) : 1113 - 1124